{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:55:21Z","timestamp":1770440121825,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 81101958"],"award-info":[{"award-number":["NSFC 81101958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbrc.2013.02.089","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T11:18:26Z","timestamp":1362655106000},"page":"232-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer"],"prefix":"10.1016","volume":"433","author":[{"given":"X.D.","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.Q.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.02.089_b0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2013.02.089_b0010","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2013.02.089_b0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/88.19.1361","article-title":"Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer","volume":"88","author":"Burger","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2013.02.089_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2013.02.089_b0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","article-title":"Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers","volume":"35","author":"Johannsson","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2013.02.089_b0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2013.02.089_b0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00304-X","article-title":"BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function","volume":"105","author":"Cantor","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2013.02.089_b0040","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng1625","article-title":"The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J","volume":"37","author":"Levitus","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2013.02.089_b0045","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1073\/pnas.0308717101","article-title":"The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations","volume":"101","author":"Cantor","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.02.089_b0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ng1627","article-title":"The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair","volume":"37","author":"Bridge","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2013.02.089_b0055","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1128\/MCB.00961-07","article-title":"Activation of BRCA1\/BRCA2-associated helicase BACH1 is required for timely progression through S phase","volume":"27","author":"Kumaraswamy","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2013.02.089_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/fon.10.191","article-title":"Hereditary breast cancer and the BRCA1-associated FANCJ\/BACH1\/BRIP1","volume":"7","author":"Cantor","year":"2011","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrc.2013.02.089_b0065","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1158\/1078-0432.CCR-08-0087","article-title":"A novel breast cancer-associated BRIP1 (FANCJ\/BACH1) germ-line mutation impairs protein stability and function","volume":"14","author":"De Nicolo","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2013.02.089_b0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6604847","article-title":"A recurrent truncating germline mutation in the BRIP1\/FANCJ gene and susceptibility to prostate cancer","volume":"100","author":"Kote-Jarai","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2013.02.089_b0075","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","article-title":"BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer","volume":"127","author":"Wong","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2013.02.089_b0080","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1371\/journal.pone.0000268","article-title":"Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer","volume":"2","author":"Song","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2013.02.089_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2012.04.112","article-title":"Polymorphisms in the glutamate decarboxylase 1 gene associated with heroin dependence","volume":"422","author":"Wu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.02.089_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neulet.2011.03.072","article-title":"Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence","volume":"495","author":"Jia","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2013.02.089_b0160","doi-asserted-by":"crossref","unstructured":"R. Mori, K. Yoshida, T. Tanahashi, K. Yawata, J. Kato, N. Okumura, Y. Tsutani, M. Okada, N. Oue, W. Yasui, Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells, Gastric Cancer (2012), PMID: 22968820, http:\/\/dx.doi.org\/10.1007\/s10120-012-0191-0. [Epub ahead of print].","DOI":"10.1007\/s10120-012-0191-0"},{"key":"10.1016\/j.bbrc.2013.02.089_b0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","article-title":"The BRCT domain is a phospho-protein binding domain","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.02.089_b0105","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2013.02.089_b0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ijc.10947","article-title":"BACH1 517C\u2192T transition impairs protein translocation to nucleus: a role in breast cancer susceptibility?","volume":"104","author":"Lei","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2013.02.089_b0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.10214","article-title":"No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22","volume":"98","author":"Luo","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2013.02.089_b0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.12.031","article-title":"BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations","volume":"245","author":"Ahn","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2013.02.089_b0125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2013.02.089_b0130","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2013.02.089_b0135","first-page":"447","article-title":"Association of Fanconi\u2019s anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases","volume":"29","author":"Wilkinson","year":"1984","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.bbrc.2013.02.089_b0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/187152008784220285","article-title":"BRCA\u2013FA pathway as a target for anti-tumor drugs","volume":"8","author":"Litman","year":"2008","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bbrc.2013.02.089_b0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia\u2013BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"Taniguchi","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2013.02.089_b0150","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.onc.1207256","article-title":"Inactivation of the Fanconi anemia\/BRCA pathway in lung and oral cancers: implications for treatment and survival","volume":"23","author":"Marsit","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2013.02.089_b0155","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat. Genet."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:04:06Z","timestamp":1757761446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0006291X13003744"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.089","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}